Skip to content

Adenosine Administration during and after Primary percutaneous coronary intervention in acute myocardial infarction – a Randomized Controlled Trial (ADAPT).

Effectiveness of intracoronary adenosine administration compared to placebo on myocardial perfusion in patients undergoing primary PCI.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22898
Enrollment
450
Registered
2007-09-27
Start date
2007-08-22
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. Percutaneous coronary intervention

Interventions

Intracoronary adenosine injection versus placebo.

Sponsors

University Medical Center Groningen, Thoraxcenter, Dept Cardiology.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. A diagnosis of acute MI defined by chest pain suggestive for myocardial ischemia for at least 30 minutes, with a time from onset of symptoms of less than 12 hours, before hospital admission. 2. An ECG with ST- segment deviation of more than 0.1 mV in 2 or more leads. 3. Thrombus aspiration performed. 4. Verbal followed by written informed consent. 5. 18 years or older.

Exclusion criteria

Exclusion criteria: 1. Need for emergency coronary artery bypass grafting (CABG). 2. Presence of cardiogenic shock. 3. Known existence of a life-threatening disease with a life expectancy of less than 6 months. 4. Receiving pharmacotherapy for chronic obstructive pulmonary disease (COPD). 5. Inability to provide informed consent.

Design outcomes

Primary

MeasureTime frame
Residual ST-segment deviation at 30 to 60 minutes after the procedure.

Secondary

MeasureTime frame
1. Myocardial blush grade; 2. ST-segment deviation resolution; 3. Enzymatic infarct size; 4. Distal embolization on coronary angiography; 5. Post-procedural TIMI flow; 6. Clinical outcome at 30 days and 12 months.

Contacts

Public ContactPieter-Jan Vlaar

University Medical Center PO Box 30 0001

p.j.j.vlaar@throrax.umcg.nl+31 (0)50 3611413

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)